Hormone Therapy News

Epicardial adipose tissue accumulation may slow down in women who were recently menopausal and were taking oral conjugated equine estrogens, according to a secondary analysis of the KEEPS trial published in the Journal of the American Heart Association.

Postmenopausal women assigned to testosterone therapy reported improvements in a variety of sexual domains vs. women assigned to placebo or estrogen, including frequency in satisfying events, arousal and orgasm, according to findings from a large meta-analysis of randomized controlled trials.

Each month in its cover story, Endocrine Today offers comprehensive reporting on issues of interest to practicing endocrinologists, diabetes educators and other clinicians.

To address barriers transgender people face when trying to access culturally competent and appropriate medical care, the ACP published a guide to help primary care physicians understand medical issues specific to transgender patients in the Annals of Internal Medicine.

The off-label use of recombinant human growth hormone as an anti-aging “wonder drug” — despite evidence suggesting serious associated risks — continues to rise in the United States and worldwide, an issue that is confounding endocrinologists who note that lower levels of GH could actually be protective in aging.

Endocrine Today has compiled a list of the top five news reports with expert perspectives posted in May. Healio.com/Endocrinology readers were interested in a drop in diabetes incidence, an increase in pediatric DKA cases, benefits of bariatric surgery for teens, and more.

Costs for the 49 top-selling brand-name prescription drugs in the United States increased by a median 76% between 2012 and 2017, with all but one drug displaying regular annual or biannual price increases, according to an analysis of pharmacy claims data published in JAMA Network Open.

Nearly one-third of men who attended a gym used anabolic steroids despite having at least some understanding of their adverse effects, according to data presented at the European Congress of Endocrinology.

Endocrine Today has compiled a list of the top 10 news reports posted from meeting news coverage during the first few months of 2019.

Transgender adults who initiated gender-affirming hormone therapy experienced decreased bone resorption and increased bone mineral density at 1 year, according to findings published in the Journal of Bone and Mineral Research.